Accession Number : ADA299890
Title : Development of a Sampling Strategy for Disease and Non-Battle Injury (DNBI) Data Rates.
Descriptive Note : Final rept. Jan 92-Jan 93,
Corporate Author : NAVAL HEALTH RESEARCH CENTER SAN DIEGO CA
Personal Author(s) : Show, Ivan T. ; White, Martin R.
PDF Url : ADA299890
Report Date : JUL 1992
Pagination or Media Count : 92
Abstract : The goal of this project was to develop a statistical sampling scenario suitable for determining Disease and Non-Battle Injury (DNBI) rates. The target population was the United States Navy (USN) and Marine Corps (USMC). The purpose of the project was to develop methods by which DNBI rates could be analyzed, projected, and compared among USN and USMC units. Specifically, the methods developed were to be capable of detecting a two-fold increase or decrease between DNBI rates for different units during the same time period or for the same units between different time periods. The Naval Health Research Center (NHRC) must deal with the realities of projecting DNBI rates that are scientifically and statistically meaningful as well as being useful at USN staff and command levels. The primary reason for reporting DNBI rates is to project medical-care requirements for peacetime operations, for wartime redeployment, and for determining operational readiness. For this reason, it was recognized that relatively simple and straightforward representations of DNBI rates were required. Therefore, major problems were how to reduce the sheer number of International Classification of Diseases, Revision 9, Clinical Modification (ICD9-CM) reporting categories and how to manage the complexity of the USN and USMC populations.
Descriptors : *CLINICAL MEDICINE, *DISEASES, *SAMPLING, *WOUNDS AND INJURIES, SCENARIOS, MILITARY PERSONNEL, MARINE CORPS, PEACETIME, OPERATIONAL READINESS, POPULATION, STATISTICAL SAMPLES, ILLNESS, MILITARY MEDICINE, CLASSIFICATION, INTERNATIONAL, DATA RATE, HEALTH CARE FACILITIES.
Subject Categories : Anatomy and Physiology
Medicine and Medical Research
Distribution Statement : APPROVED FOR PUBLIC RELEASE